くすりのしおり

Injection
Published: 5/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
PREVYMIS Intravenous Infusion 240mg
 Active ingredient:
Letermovir
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine inhibits the DNA-terminase complex required for replication of cytomegalovirus, thereby suppressing viral reproduction.
It is usually used to suppress the development of cytomegalovirus infection in patients undergoing allogeneic hematopoietic stem cell transplantation.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, inject by intravenous infusion over about 60 minutes once a day. It may be administered concomitantly with cyclosporine.
  • Ask the doctor about the treatment span.

Precautions while taking this medicine

  • If you have renal dysfunction or use this medicine for a long period, you may receive periodical renal function tests. In this case, keep all designated test schedules.
  • In animal experiments, teratogenicity has been reported. If you have a possibility of pregnancy, avoid pregnancy while you are using this medicine and for a certain period of time after you discontinue this medicine.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include nausea, diarrhea and vomit. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
No pertinent entries.
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.